Subscribe to Newsletter
Business & Regulation Business Practice, Digital Technologies

In Silico Insight

A report published by Accenture and Phesi shows that synthetic data can help drive faster, more efficient clinical trials. According to the document, AI systems that analyze electronic medical records and track patient outcomes allow for new data on trial protocols and results to be generated easily. However, the collaborators also point out that there are barriers to implementation. Often, pharma companies do not have access to data from varied sources and can also refuse to share the data they generate with others, preventing accurate statistical analysis.

“Once the availability of data is addressed, an investment into technology, skills, and leadership is a must,” the report states. “Pharma companies need to do more to identify and adopt advanced technologies to work with the data needed for in-silico clinical trials. R&D leaders will have to be bold in defining their next steps.”

Read the full report at

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Maryam Mahdi

Deputy Editor

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine